Skip to main content
logo
Hikma Pharmaceuticals PLC (HKMPY)
OTCMKTS · Delayed Price · Currency is USD
54.41
+1.01 (1.90%)
Jul 11, 2025, 3:45 PM EDT

Hikma Pharmaceuticals Revenue

In the year 2024, Hikma Pharmaceuticals had annual revenue of $3.13B with 8.77% growth. Hikma Pharmaceuticals had revenue of $1.56B in the half year ending December 31, 2024, with 19.48% growth.

Revenue
3.13B
Revenue Growth
+8.77%
P/S Ratio
1.87
Revenue / Employee
329.16K
Employees
9,500
Market Cap
5.84B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 3.13B 252.00M 8.77%
Dec 31, 2023 2.88B 358.00M 14.22%
Dec 31, 2022 2.52B -36.00M -1.41%
Dec 31, 2021 2.55B 212.00M 9.06%
Dec 31, 2020 2.34B 134.00M 6.07%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Elite Pharmaceuticals 84.04M
Glass House Brands 215.62M
American Oncology Network 1.76B
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

Hikma Pharmaceuticals News

More News